BPC-157 and Cyclic Glycine-Proline Interaction
BPC-157 and Cyclic Glycine-Proline have a compatible interaction with 90% confidence. Different pathways; BPC-157 promotes tissue repair, cGP modulates IGF-1 These compounds primarily affect different organ systems.
Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
View full profileCyclic Glycine-Proline
IGF-1 Bioavailability Regulator & Neuroprotective Peptide
Competes with IGF-1 for IGFBP-3 binding, normalizing bioavailable IGF-1 levels. Acts as positive allosteric modulator of AMPA and GABA-A receptors.
View full profileCombined Organ Load
Frequently Asked Questions
Can I take BPC-157 with Cyclic Glycine-Proline?
Yes, BPC-157 and Cyclic Glycine-Proline can generally be taken together. Different pathways; BPC-157 promotes tissue repair, cGP modulates IGF-1
Is BPC-157 and Cyclic Glycine-Proline safe together?
Based on documented research, this combination is considered compatible. No critical safety flags identified for this pair.
What are the interactions between BPC-157 and Cyclic Glycine-Proline?
Different pathways; BPC-157 promotes tissue repair, cGP modulates IGF-1 This assessment has 90% confidence and is based on documented research data.
How should I time BPC-157 and Cyclic Glycine-Proline?
BPC-157 has a half-life of <30 minutes and Cyclic Glycine-Proline has a half-life of Extended stability (more stable than linear GPE precursor). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.